icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 22-25, 2016, Boston MA
Back grey_arrow_rt.gif
 
 
 
Pharmacokinetics, Safety and Efficacy of Maraviroc in Pediatric Patients With R5 HIV
 
 
  Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
 
Carlo Giaquinto,1 Muthuhadini Patience Mawela,2 Kulkanya Chokephaibulkit,3 Annie Fang,4 Elna van der Ryst,5 Srinivas Rao Valluri,4 Manoli Vourvahis,4 Rebecca Zhang-Roper,6 Lynn McFadyen,7 Jayvant Heera8 1University of Padova, Padova, Italy; 2Sefako Makgatho Health Sciences University, Pretoria, South Africa; 3Siriraj Hospital, Mahidol University, Bangkok Noi, Bangkok, Thailand; 4Pfizer Inc, New York, NY, USA; 5Pfizer Inc, The Research Network, Sandwich, Kent, UK; 6GlaxoSmithKline, Stockley Park, UK; 7Pfizer Inc, Sandwich, Kent, UK, 8Pfizer Inc, Groton, CT, USA

CROI1

CROI2

CROI3

CROI4

CROI5

CROI6